Isoliquiritigenin from licorice root suppressed neovascularisation in experimental ocular angiogenesis models

British Journal of Ophthalmology

Volumn 95, Issue 9, 2011, Pages 1309-1315

  Jhanji, Vishal ^a   Liu, Huanming ^a   Law, Kasin ^a   Lee, Vincent Yau Wing ^a   Huang, Shao Fen ^b   Pang, Chi Pui ^a   Yam, Gary Hin Fai ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Shantou University Medical College   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; EYE DROPS; ISOLECTIN B4; ISOLIQUIRITIGENIN; PIGMENT EPITHELIUM DERIVED FACTOR; SILVER NITRATE; VASCULOTROPIN;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARGON LASER; ARTICLE; ASSAY; CAUTERIZATION; CHICK EMBRYO; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; CORNEA VASCULARIZATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; EMBRYO; EX VIVO CHICK CHORIOALLANTOIC MEMBRANE ASSAY; EX VIVO STUDY; EXPERIMENTAL MODEL; EYE FUNDUS; FEMALE; FLUORESCENCE ANGIOGRAPHY; GLYCYRRHIZA; GRIFFONIA; GRIFFONIA SIMPLICIFOLIA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; LASER COAGULATION; MOUSE; NONHUMAN; PLANT ROOT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA NEOVASCULARIZATION; RETINOPATHY; SUBRETINAL NEOVASCULARIZATION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CELLS, CULTURED; CHALCONES; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; CHOROIDAL NEOVASCULARIZATION; CORNEAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; EYE PROTEINS; FEMALE; FLUORESCEIN ANGIOGRAPHY; FLUORESCENT ANTIBODY TECHNIQUE; FUNDUS OCULI; GLYCYRRHIZA; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NERVE GROWTH FACTORS; OPHTHALMIC SOLUTIONS; PLANTS; RETINAL NEOVASCULARIZATION; SERPINS; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80052128201     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2011-300110     Document Type: Article

References (49)

1. Bressler NM. Antiangiogenic approaches to age-related macular degeneration today. Ophthalmology 2009;116:S15-23.
2. Crawford TN, Alfaro DV, Kerrison JB, et al. Diabetic retinopathy and angiogenesis. Curr Diabetes Rev 2009;5:8-13.
3. Shazly TA, Latina MA. Neovascular glaucoma: Etiology, diagnosis and prognosis. Semin Ophthalmol 2009;24:113-21.
4. Ellenberg D, Azar DT, Hallak JA, et al. Novel aspects of corneal angiogenic and lymphangiogenic privilege. Prog Retin Eye Res 2010;29:208-48.
5. Rajappa M, Saxena P, Kaur J. Ocular angiogenesis: Mechanisms and recent advances in therapy. Adv Clin Chem 2010;50:103-21.
6. Cao W, Tombran-Tink J, Chen W, et al. Pigment epithelium-derived factor protects cultured retinal neurons against hydrogen peroxide-induced cell death. J Neurosci Res 1999;57:789-800. (Pubitemid 29416109)
7. Shin SH, Kim JC, Chang SI, et al. Recombinant kringle 1-3 of plasminogen inhibits rabbit corneal angiogenesis induced by angiogenin. Cornea 2000;19:212-17. (Pubitemid 30140826)
8. Narasaki R, Kuribayashi H, Shimizu K, et al. Bacillolysin MA, a novel bacterial metalloproteinase that produces angiostatin-like fragments from plasminogen and activates protease zymogens in the coagulation and fibrinolysis systems. J Biol Chem 2005;280:14278-87. (Pubitemid 40517330)
9. Gabison E, Chang JH, Hernandez-Quintela E, et al. Anti-angiogenic role of angiostatin during corneal wound healing. Exp Eye Res 2004;78:579-89. (Pubitemid 38183337)
10. Chang JH, Javier JA, Chang GY, et al. Functional characterization of neostatins, the MMP-derived, enzymatic cleavage products of type XVIII collagen. FEBS Lett 2005;579:3601-6. (Pubitemid 40897698)
11. Kape R, Parniske M, Brandt S, et al. Isoliquiritigenin, a strong nod gene- and glyceollin resistance-inducing flavonoid from soybean root exudate. Appl Environ Microbiol 1992;58:1705-10.
12. Kobayashi S, Miyamoto T, Kimura I, et al. Inhibitory effect of isoliquiritin, a compound in licorice root, on angiogenesis in vivo and tube formation in vitro. Biol Pharm Bull 1995;18:1382-6.
13. Dixon RA, Sumner LW. Legume natural products: Understanding and manipulating complex pathways for human and animal health. Plant Physiol 2003;131:878-85. (Pubitemid 36400327)
14. Nerya O, Vaya J, Musa R, et al. Glabrene and isoliquiritigenin as tyrosinase inhibitors from licorice roots. J Agric Food Chem 2003;51:1201-7.
15. Cuendet M, Oteham CP, Moon RC, et al. Quinone reductase induction as a biomarker for cancer chemoprevention. J Nat Prod 2006;69:460-3.
16. Sheela ML, Ramakrishna MK, Salimath BP. Angiogenic and proliferative effects of the cytokine VEGF in Ehrlich ascites tumor cells is inhibited by Glycyrrhiza glabra. Intl Immunopharmacol 2006;6:494-8. (Pubitemid 43120464)
17. Kwon HM, Choi YJ, Choi JS, et al. Blockade of cytokine-induced endothelial cell adhesion molecule expression by licorice isoliquiritigenin through NF-kappaB signal disruption. Exp Biol Med (Maywood) 2007;232:235-45.
18. Cuendet M, Guo J, Luo Y, et al. Cancer chemopreventive activity and metabolism of isoliquiritigenin, a compound found in licorice. Cancer Prev Res (Phila) 2010;3:221-32.
19. Kang SW, Choi JS, Choi YJ, et al. Licorice isoliquiritigenin dampens angiogenic activity via inhibition of MAPK-responsive signaling pathways leading to induction of matrix metalloproteinases. J Nutr Biochem 2010;21:55-65.
20. Sun ZJ, Chen G, Zhang W, et al. Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: Its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase. J Pharmacol Exp Ther 2010;334:500-12.
21. Lam W, Bussom S, Guan F, et al. The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity. Sci Transl Med 2010;2:45-59.
22. Cao L, Liu HM, Lam DS, et al. In vitro screening for angiostatic potential of herbal chemicals. Invest Ophthalmol Vis Sci 2010;51:6658-64.
23. Dohle DS, Pasa SD, Gustmann S, et al. Chick ex ovo culture and ex ovo CAM assay: How it really works. J Vis Exp. Published Online First: 30 Nov 2009. doi:10.3791/1620.
24. Krzystolik MG, Afshari MA, Adamis AP, et al. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 2002;120:338-46. (Pubitemid 34250056)
25. Lebrun-Julien F, Bertrand MJ, De Backer O, et al. ProNGF induces TNFalpha-dependent death of retinal ganglion cells through a p75NTR non-cell-autonomous signaling pathway. Proc Natl Acad Sci U S A 2010;107:3817-22.
26. Kvanta A. Ocular angiogenesis: The role of growth factors. Acta Ophthalmol Scand 2006;84:82-8.
27. Qazi Y, Maddula S, Ambati BK. Mediators of ocular angiogenesis. J Genet 2009;88:495-515.
28. Ahmad N, Feyes DK, Nieminen AL, et al. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 1997;89:1881-6. (Pubitemid 28009824)
29. Martin AR, Villegas I, La Casa C, et al. Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats. Biochem Pharmacol 2004;67:1399-410. (Pubitemid 38315105)
30. Stephanou A. Role of STAT-1 and STAT-3 in ischaemia/reperfusion injury. J Cell Mol Med 2004;8:519-25. (Pubitemid 44145484)
31. Cooper R, Morre DJ, Morre DM. Medicinal benefits of green tea: Part II. review of anticancer properties. J Altern Complement Med 2005;11:639-52. (Pubitemid 41279080)
32. Gagliano N, Moscheni C, Torri C, et al. Effect of resveratrol on matrix metalloproteinase-2 (MMP-2 and Secreted Protein Acidic and Rich in Cysteine (SPARC) on human cultured glioblastoma cells. Biomed Pharmacother 2005;59:359-64. (Pubitemid 41219649)
33. Ahn MR, Kunimasa K, Ohta T, et al. Suppression of tumor-induced angiogenesis by Brazilian propolis: major component artepillin C inhibits in vitro tube formation and endothelial cell proliferation. Cancer Lett 2007;252:235-43. (Pubitemid 46809795)
34. Keshavarz M, Mostafaie A, Mansouri K, et al. Inhibition of corneal neovascularization with propolis extract. Arch Med Res 2009;40:59-61.
35. Sen T, Moulik S, Dutta A, et al. Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Life Sci 2009;84:194-204.
36. Remtulla S, Hallett PE. A schematic eye for the mouse, and comparisons with the rat. Vision Res 1985;25:21-31. (Pubitemid 15165475)
37. Kwon GT, Cho HJ, Chung WY, et al. Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling. J Nutr Biochem 2009;20:663-76.
38. Ma J, Fu NY, Pang DB, et al. Apoptosis induced by isoliquiritigenin in human gastric cancer MGC-803 cells. Planta Med 2001;67:754-7. (Pubitemid 33044487)
39. Jung JI, Lim SS, Choi HJ, et al. Isoliquiritigenin induces apoptosis by depolarizing mitochondrial membranes in prostate cancer cells. J Nutr Biochem 2006;17:689-96. (Pubitemid 44380373)
40. Lee CK, Son SH, Park KK, et al. Isoliquiritigenin inhibits tumor growth and protects the kidney and liver against chemotherapy-induced toxicity in a mouse xenograft model of colon carcinoma. J Pharmacol Sci 2008;106:444-51.
41. Philipp W, Speicher L, Humpel C. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Invest Ophthalmol Vis Sci 2000;41:2514-22. (Pubitemid 30624378)
42. Ogata N, Wada M, Otsuji T, et al. Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2002;43:1168-75. (Pubitemid 34258289)
43. Avery RL. Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina 2006;26:352-4. (Pubitemid 44318195)
44. Lien S, Lowman HB. Therapeutic anti-VEGF antibodies. Handb Exp Pharmacol 2008;181:131-50.
45. Xu X, Zhang SS, Barnstable CJ, et al. Molecular phylogeny of the antiangiogenic and neurotrophic serpin, pigment epithelium derived factor in vertebrates. BMC Genomics 2006;7:248.
46. Dawson DW, Volpert OV, Gillis P, et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999;285:245-8. (Pubitemid 29329995)
47. Ogata N, Matsuoka M, Imaizumi M, et al. Decrease of pigment epithelium-derived factor in aqueous humor with increasing age. Am J Ophthalmol 2004;137:935-6. (Pubitemid 38582050)
48. Tong JP, Chan WM, Liu DT, et al. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol 2006;141:456-62. (Pubitemid 43265948)
49. Zhang SX, Wang JJ, Gao G, et al. Pigment epithelium-derived factor (PEDF) is an endogenous anti-inflammatory factor. FASEB J 2006;20:323-5. (Pubitemid 46671158)